☆ 4.1 Article

Pharmacokinetic-pharmacodynamic modeling of the active components of Shenkang injection in rats with chronic renal failure and its protective effect on damaged renal cells

BIOPHARMACEUTICS & DRUG DISPOSITION (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Immunology

Neoxanthin alleviates the chronic renal failure-induced aging and fibrosis by regulating inflammatory process

Jiali Fang et al.

Summary: In this study, the potential therapeutic effects of neoxanthin on chronic renal failure were investigated. It was found that neoxanthin could delay the progression of the disease and alleviate aging and fibrosis caused by chronic renal failure.

INTERNATIONAL IMMUNOPHARMACOLOGY (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Exosome-encapsulated miR-26a attenuates aldosterone-induced tubulointerstitial fibrosis by inhibiting the CTGF/SMAD3 signaling pathway

Hui Zheng et al.

Summary: Renal tubulointerstitial fibrosis (TIF) is a key process in the progression of chronic kidney disease, with excessive activation of the renin-angiotensin-aldosterone system playing a crucial role. This study aimed to investigate the effect of miR-26a on aldosterone-induced TIF and found that exosome-delivered miR-26a could alleviate TIF, tubular injury, and epithelial-mesenchymal transition. Mechanistically, miR-26a inhibited connective tissue growth factor expression by directly binding to its 3'-UTR and inhibiting the activation of SMAD3. These findings provide new insights into the treatment of chronic kidney disease.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Effects of borneol combined with astragaloside IV and Panax notoginseng saponins regulation of microglia polarization to promote neurogenesis after cerebral ischaemia

Huang Ding et al.

Summary: The study aimed to investigate the effect of BAP on promoting neurogenesis by regulating microglia polarization after CI/R in rats. BAP can inhibit the activation of TLR4/MyD88/NF kappa B, regulate the polarization of microglia from M1 type to M2 type, and inhibit inflammatory response, thus reducing CI/R injury and promoting neurogenesis.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2023)

添加到收藏夹

Article Plant Sciences

Hydroxysafflor yellow A regulates lymphangiogenesis and inflammation via the inhibition of PI3K on regulating AKT/mTOR and NF-ΚB pathway in macrophages to reduce atherosclerosis in ApoE-/- mice

Xiaoteng Feng et al.

Summary: The study aimed to uncover the key site of Hydroxysafflor yellow A (HSYA) in improving atherosclerosis by regulating macrophage-induced inflammation and lymphangiogenesis. In vitro and in vivo experiments showed that HSYA affects inflammation and inflammation-associated lymphangiogenesis via suppressing PI3K to affect AKT/mTOR and NF-B pathway activation in macrophages, demonstrating a comprehensive protective effect on atherosclerosis.

PHYTOMEDICINE (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Emodin ameliorates renal injury and fibrosis via regulating the miR-490-3p/HMGA2 axis

Liulin Wang et al.

Summary: Emodin has protective effects on renal fibrosis by regulating the miR-490-3p/HMGA2 signaling pathway.

FRONTIERS IN PHARMACOLOGY (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

Clinical effect of rhubarb on the treatment of chronic renal failure: A meta-analysis

Wei Huang et al.

Summary: This systematic review and meta-analysis evaluated the efficacy and safety of rhubarb in the treatment of chronic renal failure. The results showed that rhubarb has a positive therapeutic effect, but further research is needed to evaluate its efficacy and safety.

FRONTIERS IN PHARMACOLOGY (2023)

添加到收藏夹

Article Pharmacology & Pharmacy

PK/PD modeling to characterize placebo and treatment effect of omalizumab for chronic spontaneous urticaria

Elise Oh et al.

Summary: The pharmacokinetic and pharmacodynamic characteristics of omalizumab in chronic spontaneous urticaria have not been fully characterized. This study aims to describe the population pharmacokinetics and pharmacodynamics of omalizumab and develop a drug effect model for urticaria treatment. The developed model incorporates omalizumab-IgE binding and turnover and adequately describes the pharmacokinetics and pharmacodynamics of omalizumab. It has the potential to aid in understanding variability in pharmacokinetics/pharmacodynamics and response to omalizumab treatment.

CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2023)

添加到收藏夹

Article Oncology

The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β

Gang Wang et al.

Summary: The study demonstrates that PFD can prevent the progression of renal cancer by inhibiting the production of TGF-beta and its downstream signaling pathway in cancer cells. It also regulates the tumor microenvironment to suppress the recruitment of immunosuppressive cells.

CANCER BIOLOGY & THERAPY (2022)

添加到收藏夹

Article Chemistry, Medicinal

Quercetin regulates vascular endothelium function in chronic renal failure via modulation of Eph/Cav-1 signaling

Jing Chen et al.

Summary: This study aimed to uncover the impacts of Quercetin (Quer) on vascular endothelial cells in a chronic renal failure (CRF) rat model and human umbilical vein endothelial cells (HUVECs) stimulated by lipopolysaccharide (LPS) and serum from CRF rats. The results showed that Quer improved renal function impairment and endothelial injury in vivo, boosted cell proliferation, suppressed apoptosis, elevated NO and eNOS levels, and modulated Eph/Cav-1 signaling pathway.

DRUG DEVELOPMENT RESEARCH (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Genetic or siRNA inhibition of MBD2 attenuates the UUO- and I/R-induced renal fibrosis via downregulation of EGR1

Kai Ai et al.

Summary: This study reveals the role and mechanism of MBD2 in renal fibrosis. MBD2 promotes ECM production by regulating the activity of EGR1. Inhibition of MBD2 reduces renal fibrosis, suggesting it as a potential target for the treatment of fibrotic kidney disease.

MOLECULAR THERAPY-NUCLEIC ACIDS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Renal Fibrosis in Lupus Nephritis

Savino Sciascia et al.

Summary: Fibrosis is a pathological process that can affect the kidney, leading to persistent inflammation or long-term injury. Recently, there has been increasing attention on interstitial fibrosis and tubular atrophy as markers of injury severity, predictors of treatment response, and prognostic factors for renal outcome in lupus nephritis (LN). This review explores the mechanisms of fibrogenesis in LN and the importance of the chronicity index in predicting treatment response and renal prognosis. Understanding the cellular and molecular pathways involved in fibrosis in LN could help identify individuals at higher risk of chronic kidney disease and develop new therapeutic strategies for lupus patients.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Cell Biology

Protective effect of Astragalus membranaceus and Astragaloside IV in sepsis-induced acute kidney injury

Jia-Long Tang et al.

Aging-US (2022)

添加到收藏夹

Article Integrative & Complementary Medicine

ShenKang Injection Attenuates Renal Fibrosis by Inhibiting EMT and Regulating the Wnt/β-Catenin Pathway

Hui-Ting Wei et al.

Summary: Shenkang Injection (SKI), a traditional Chinese medicine injection, has been found to have anti-fibrotic effects in the treatment of chronic kidney disease. The study suggests that SKI may inhibit renal fibrosis by regulating the Wnt/beta-catenin pathway and inhibiting epithelial-mesenchymal transition (EMT). The results show that SKI reduces morphological changes and collagen deposition associated with renal fibrosis, and improves kidney function by lowering blood urea nitrogen and serum creatinine levels.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2022)

添加到收藏夹

Article Food Science & Technology

Tanshinone IIA improves diabetes-induced renal fibrosis by regulating the miR-34-5p/Notch1 axis

Lizhi Zhang et al.

Summary: This study evaluated the improvement of tanshinone in renal fibrosis in vitro and in vivo. The results showed that tanshinone supplementation significantly increased fibrosis area and apoptosis cell rate, and this effect was dose-dependent. By regulating miRNA-34a-5p, tanshinone improved DN-induced renal fibrosis.

FOOD SCIENCE & NUTRITION (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Oncoprotein DJ-1 interacts with mTOR complexes to effect transcription factor Hif1α-dependent expression of collagen I (α2) during renal fibrosis

Falguni Das et al.

Summary: This study demonstrates that DJ-1 regulates the expression of collagen I (alpha 2) induced by TGF beta through an mTOR- and PKC beta II-dependent mechanism, and identifies Hif1 alpha as an important transcription factor in this regulation.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

添加到收藏夹

Article Plant Sciences

A network pharmacology-based study on the mechanism of astragaloside IV alleviating renal fibrosis through the AKT1/GSK-3β pathway

Xinwei Yu et al.

Summary: In this study, the anti-fibrotic effect of Astragaloside IV (AS-IV) and its mechanism of action were investigated using network pharmacology, molecular docking, and surface plasmon resonance techniques. AS-IV was found to alleviate renal fibrosis through the AKT1/GSK-3 beta pathway, inhibiting the expression of fibrotic markers in renal cells and rats. Additionally, the study showed that network pharmacology is a powerful tool for exploring the pharmacological mechanisms of drugs.

JOURNAL OF ETHNOPHARMACOLOGY (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Estimation of Renin enzyme activity and some biochemical parameters among chronic renal failure patients in Tikrit city

Tafaoul Jaber Hameed et al.

Summary: This study aims to estimate some parameters in the serum of chronic renal failure patients, and the results show significant impacts of chronic renal failure on renin levels, electrolytes, and liver function tests.

JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY (2022)

添加到收藏夹

Article Chemistry, Medicinal

Pharmacokinetics and Metabolism Research of Shenkang Injection in Rats Based on UHPLC-MS/MS and UHPLC-Q-Orbitrap HRMS

Xiaofang Jiang et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

添加到收藏夹

Article Chemistry, Medicinal

Emodin Retarded Renal Fibrosis Through Regulating HGF and TGFβ-Smad Signaling Pathway

Fan Yang et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Application of the relationship between pharmacokinetics and pharmacodynamics in drug development and therapeutic equivalence: a PEARRL review

Ioannis Loisios-Konstantinidis et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Tanshinol inhibits the growth, migration and invasion of hepatocellular carcinoma cells via regulating the PI3K-AKT signaling pathway

Pingting Zhu et al.

ONCOTARGETS AND THERAPY (2019)

添加到收藏夹

Article Pharmacology & Pharmacy

Protective cerebrovascular effects of hydroxysafflor yellow A (HSYA) on ischemic stroke

Yang Sun et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2018)

添加到收藏夹

Article Chemistry, Analytical

Chemical profiling and quantification of ShenKang injection, a systematic quality control strategy using ultra high performance liquid chromatography with Q Exactive hybrid quadrupole orbitrap high-resolution accurate mass spectrometry

Tanye Xu et al.

JOURNAL OF SEPARATION SCIENCE (2017)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.